← Alle mensen

LP

Laia Paré

10 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analyse.
The Lancet. Oncology · 2025-08
HER2DX genomische test bij HER2-positief mammacarcinoom: APHINITY analyse
Clinical cancer research : an official journal of the American Association for Cancer Research · 13 september 2024
Preoperatieve ribociclib-letrozol versus chemotherapie: QoL FELINE analyse
European journal of cancer (Oxford, England : 1990) · 2022-10
Intrinsieke subtypes en CDK4/6-remmer werkzaamheid: MONALEESA correlatie
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 mei 2021
PAM50MET prognostisch model bij gemetastaseerd HR-positief mammacarcinoom
Clinical cancer research : an official journal of the American Association for Cancer Research · 1 december 2020
PIK3CA-mutatie en trastuzumab-duur bij HER2-positief mammacarcinoom: ShortHER analyse
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 november 2020
Palbociclib plus trastuzumab bij HER2-positief gevorderd mammacarcinoom: SOLTI-1303 PATRICIA fase II
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 november 2020
Multivariabele prognostische score bij HER2-positief vroeg mammacarcinoom
The Lancet. Oncology · 2020-11
Ribociclib plus letrozol versus chemotherapie bij postmenopauzaal HR-positief mammacarcinoom: RIGHT Choice
The Lancet. Oncology · 2020-01
PAM50-gebaseerde chemo-endocriene score bij HR-positief mammacarcinoom met intermediair recidiefrisico
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 juni 2017